COMP <GO>
AVTR vs MRK // RETURN ON INVESTED CAPITAL (ROIC)
Avantor Inc. (NYSE) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: AVTR 2
— MRK 12
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: MRK
LAST: $16.05 (-3.78%) • MKT CAP: $11.30B
roic
-2.10%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
roic
20.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AVTR VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AVTR | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.70% | 74.80% | -42.10 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -2.10% | 20.70% | -22.80 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.38% | 3.42% | +0.96 | AVTR | /fcf-yield <GO> |
| Operating Margin | -3.80% | 34.30% | -38.10 | MRK | /operating-margins <GO> |
| Net Profit Margin | -8.10% | 28.10% | -36.20 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | -3.40% | 1.30% | -4.70 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.88 | 5.19 | -3.31 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 6.60% | +0.30 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.1 | 56.9 | -7.76 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 0.92 | +0.09 | AVTR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 31.0x | 18.4x | +12.60 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.30B | $361.02B | -$349.72B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AVTR REV | MRK REV | AVTR GROSS % | MRK GROSS % | AVTR FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.55B | $65.01B | 32.7% | 74.8% | $495.0M | $12.36B |
| FY 2024 | $6.78B | $64.17B | 33.6% | 76.3% | $692.0M | $18.10B |
| FY 2023 | $6.97B | $60.12B | 44.0% | 44.0% | $556.5M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AVTR // BETA 1.01
MRK // BETA 0.92